[HTML][HTML] Prediction of clinically significant prostate cancer using polygenic risk models in Asians
SH Song, E Kim, E Woo, E Kwon, S Yoon… - … and clinical urology, 2022 - ncbi.nlm.nih.gov
Purpose To develop and evaluate the performance of a polygenic risk score (PRS)
constructed in a Korean male population to predict clinically significant prostate cancer …
constructed in a Korean male population to predict clinically significant prostate cancer …
Evaluation of polygenic risk scores for prediction of prostate cancer in Korean men
JJ Oh, E Kim, E Woo, SH Song, JK Kim, H Lee… - Frontiers in …, 2020 - frontiersin.org
Aims The purpose of this study is to evaluate an aggregate influence of prostate cancer
(PCa) susceptibility variants on the development of PCa in Korean men by using the …
(PCa) susceptibility variants on the development of PCa in Korean men by using the …
Predictive Performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk‐associated SNPs
J Zheng, F Liu, X Lin, X Wang, Q Ding, H Jiang… - The …, 2012 - Wiley Online Library
BACKGROUND Genome‐wide association studies (GWAS) have identified more than 30
single nucleotide polymorphisms (SNPs) that were reproducibly associated with prostate …
single nucleotide polymorphisms (SNPs) that were reproducibly associated with prostate …
[HTML][HTML] Polygenic risk score for genetic evaluation of prostate cancer risk in Asian populations: A narrative review
SH Song, SS Byun - Investigative and clinical urology, 2021 - ncbi.nlm.nih.gov
Decreasing costs of genetic testing and interest in disease inheritance has changed the
landscape of cancer prediction in prostate cancer (PCa), and guidelines now include …
landscape of cancer prediction in prostate cancer (PCa), and guidelines now include …
Application of European‐specific polygenic risk scores for predicting prostate cancer risk in different ancestry populations
Background Polygenic risk score (PRS) has shown promise in predicting prostate cancer
(PCa) risk. However, the application of PRS in non‐European ancestry was poorly studied …
(PCa) risk. However, the application of PRS in non‐European ancestry was poorly studied …
Polygenic risk score for tumor aggressiveness and early-onset prostate cancer in Asians
SH Song, E Kim, YJ Jung, HM Kim, MS Park, JK Kim… - Scientific Reports, 2023 - nature.com
We attempted to assess the performance of an ethnic-specific polygenic risk score (PRS)
designed from a Korean population to predict aggressive prostate cancer (PCa) and early …
designed from a Korean population to predict aggressive prostate cancer (PCa) and early …
Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese
S Akamatsu, A Takahashi, R Takata, M Kubo, T Inoue… - 2012 - journals.plos.org
Prostate specific antigen (PSA) is widely used as a diagnostic biomarker for prostate cancer
(PC). However, due to its low predictive performance, many patients without PC suffer from …
(PC). However, due to its low predictive performance, many patients without PC suffer from …
[HTML][HTML] Prostate cancer risk-associated genetic markers and their potential clinical utility
Prostate cancer (PCa) is one of the most common cancers among men in Western
developed countries and its incidence has increased considerably in many other parts of the …
developed countries and its incidence has increased considerably in many other parts of the …
Polygenic risk score in prostate cancer
JJ Oh, SK Hong - Current Opinion in Urology, 2022 - journals.lww.com
Emerging data from several studies regarding PRS in PCa could be the solution to adding
predictive value to PCa risk estimation. Although commercial markers are available …
predictive value to PCa risk estimation. Although commercial markers are available …
Validation of a prostate cancer polygenic risk score
Background Genome‐wide association studies have identified over 100 single‐nucleotide
polymorphisms (SNPs) associated with prostate cancer (PrCa), and polygenic risk scores …
polymorphisms (SNPs) associated with prostate cancer (PrCa), and polygenic risk scores …